Detalhe da pesquisa
1.
Neuropilin-1 and placental growth factor as prognostic factors in metastatic breast cancer.
BMC Cancer
; 24(1): 331, 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38468231
2.
Breast density and the likelihood of malignant MRI-detected lesions in women diagnosed with breast cancer.
Eur Radiol
; 33(11): 8080-8088, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646814
3.
Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor.
Acta Oncol
; 61(10): 1263-1267, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36307938
4.
High baseline Tie1 level predicts poor survival in metastatic breast cancer.
BMC Cancer
; 19(1): 732, 2019 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31340773
5.
Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma.
Acta Oncol
; 59(3): 310-314, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31564175
6.
Antibiotic Treatment is an Independent Poor Risk Factor in NSCLC But Not in Melanoma Patients Who had Received Anti-PD-1/L1 Monotherapy.
Clin Lung Cancer
; 24(4): 295-304, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36774235
7.
Radiological and pathological assessment of response to neoadjuvant CDK4/6 inhibitor and endocrine treatments in a real-life setting-initial results.
Acta Radiol Open
; 10(8): 20584601211030660, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34422318
8.
Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15-3 (CA15-3) in human plasma.
PLoS One
; 14(7): e0219480, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31344060
9.
Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer.
Clin Breast Cancer
; 19(4): e522-e533, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31029558
10.
Bevacizumab Combined with Docetaxel or Paclitaxel as First-line Treatment of HER2-negative Metastatic Breast Cancer.
Anticancer Res
; 36(12): 6431-6438, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27919965